News Trends, News Analysis, News Archive.



Related Articles

healthNews reuters.com

Social media may help chronically ill connect to doctors, fellow patients

(Reuters Health) - Social media groups that bring together patients, family, friends and healthcare providers can improve patients’ outlook and reduce their anxiety and depression, a recent U.S. study suggests.

healthNews reuters.com

U.S. less generous than European nations with development assistance

(Reuters Health) - The U.S. contributes more than any other nation in development assistance for health to low- and middle-income countries, but its generosity falls short when compared in terms of size and wealth, a new study found.

healthNews reuters.com

Perrigo lines up bid for Merck's consumer health unit: sources

LONDON/FRANKFURT (Reuters) - Generic drugmaker Perrigo has decided to enter the fray for Merck KGaA's consumer health unit, sources told Reuters, and is preparing an indicative offer for the $4.7 billion business ahead of a deadline on Friday.

healthNews reuters.com

Transgender women may get small breasts with hormones

(Reuters Health) - Transgender women who take sex hormones to feminize their bodies may not experience as much breast development as they expect, a new European study suggests.

healthNews reuters.com

Germany's Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the U.S. market, hoping for blockbuster sales despite regulators' concerns about side effects having frustrated its ambitions almost seven years ago.

domesticNews reuters.com

Turkish banker expected to testify in Iran sanctions trial in New York

(Reuters) - Mehmet Hakan Atilla, a Turkish banker accused of taking part in a scheme to help Iran evade U.S. sanctions, plans to testify in his own defense at his trial in New York, his lawyers said Thursday.

healthNews reuters.com

Brain cells develop more mutations as we age

(Reuters Health) - Brain cells - neurons - develop gene mutations over the course of a lifetime, contributing to normal aging and potentially presenting a target for treatments that stave off dementia and other types of cognitive decline, researchers say.

companyNews reuters.com

BRIEF-Medicure Acquires License To Sell Cardiovascular Drug In The U.S.

* MEDICURE ACQUIRES EXCLUSIVE LICENSE TO SELL AND MARKET BRANDED CARDIOVASCULAR DRUG IN THE U.S.

companyNews reuters.com

BRIEF-Trovagene Submits Protocol To FDA For Phase 2 Clinical Trial Of Pcm-075 In Combination With Zytiga®

* TROVAGENE SUBMITS PROTOCOL TO FDA FOR PHASE 2 CLINICAL TRIAL OF PCM-075 IN COMBINATION WITH ZYTIGA® FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

companyNews reuters.com

BRIEF-Oncosec Announces Dosing Of First Patient In Registration-Directed Phase 2B Clinical Trial

* ONCOSEC ANNOUNCES DOSING OF FIRST PATIENT IN REGISTRATION-DIRECTED PHASE 2B CLINICAL TRIAL, PISCES/KEYNOTE-695, OF IMMUNOPULSE® IL-12 IN COMBINATION WITH PEMBROLIZUMAB Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

companyNews reuters.com

BRIEF-Amicus Therapeutics Submits New Drug Application To U.S. FDA For Migalastat

* AMICUS THERAPEUTICS SUBMITS NEW DRUG APPLICATION TO U.S. FDA FOR MIGALASTAT FOR TREATMENT OF FABRY DISEASE

healthNews reuters.com

With no deal on children's health plan, U.S. states scramble for Plan B

NEW YORK/WASHINGTON (Reuters) - For Nancy Minoui of Portland, Oregon, and Crystal Lett of Dublin, Ohio, Congress' failure to fund the Children's Health Insurance Program is not some distant tale of political wrangling.

companyNews reuters.com

BRIEF-Protagonist Therapeutics Announces Final Phase 1 Study Results With Novel Hepcidin Mimetic, PTG-300

* PROTAGONIST THERAPEUTICS ANNOUNCES FINAL PHASE 1 STUDY RESULTS WITH NOVEL HEPCIDIN MIMETIC, PTG-300

healthNews reuters.com

Former Philippine President defends controversial dengue program

MANILA (Reuters) - Former Philippine President Benigno Aquino defended on Thursday his decision to implement a controversial immunization program using a new dengue vaccine in 2016, saying it was justified with millions of people at risk of being infected by the virus.

healthNews reuters.com

Treating bumps and humps: Dubai opens $10 million camel hospital

DUBAI (Reuters) - Pristine operating theaters and state-of-the-art medical equipment are featured in a new Dubai hospital that opened last week - exclusively for camels.

cnn.com

Overall teen drug use low, but marijuana edging up

Teen drinking, smoking and drug use overall are stable, but the percentage of teens using marijuana is increasing, according to a new report from the University of Michigan's Institute for Social Research.

environmentNews reuters.com

China's industrial heartland struggles in Beijing's fight against smog

SHIJIAZHUANG, China (Reuters) - Severe natural gas shortages are hitting businesses and residents across China's industrial heartland as an unprecedented government effort to clean up an environment devastated by decades of unbridled growth backfires.

companyNews reuters.com

U.S. appeals court vacates conviction of drug distributor over Botox

Dec 13 (Reuters) - A U.S. appeals court on Wednesday vacated the conviction of the owner of a wholesale drug distributor accused of selling authentic Botox and other drugs with foreign labels, dealing another setback to the government, which has struggled at times to successfully prosecute similar such cases.

healthNews reuters.com

Pfizer's second biosimilar of J&J's Remicade wins U.S. FDA approval

(Reuters) - The U.S. Food and Drug Administration approved Pfizer Inc's second biosimilar to Johnson & Johnson's blockbuster rheumatoid arthritis drug, Remicade, the company said on Wednesday.

healthNews reuters.com

Seasonal flu kills more globally than previously thought -U.S. study

CHICAGO (Reuters) - As many as 646,000 people are dying globally from seasonal influenza each year, U.S. health officials said on Wednesday, a rise from earlier assessments of the disease's death toll.

companyNews reuters.com

Turkish banker accused of helping Iran launder money seeks mistrial

NEW YORK, Dec 13 (Reuters) - Lawyers for a Turkish banker on trial in New York on charges that he helped Iran evade U.S. sanctions asked a judge on Wednesday to declare a mistrial, saying testimony by a former Turkish police investigator should not have been allowed in court.

businessNews reuters.com

Bumper crop of new drugs fails to lift big pharma R&D returns

LONDON (Reuters) - It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on research investment at leading pharmaceutical companies are down.

healthNews reuters.com

Ohio passes law barring abortion over Down syndrome diagnosis

CLEVELAND (Reuters) - Women in Ohio would be prohibited from receiving abortions because of a fetal Down syndrome diagnosis under a bill that passed the state senate on Wednesday and is heading to Republican Governor John Kasich’s desk.

companyNews reuters.com

BRIEF-First Industrial Realty Trust To Issue $300 Mln Notes In Private Offering

* FIRST INDUSTRIAL REALTY TRUST TO ISSUE $300 MILLION OF UNSECURED NOTES IN A PRIVATE PLACEMENT OFFERING Source text for Eikon: Further company coverage:

topNews reuters.com

U.S. judge orders accused New York bomber detained ahead of trial

NEW YORK (Reuters) - The Bangladeshi man accused of attempting a suicide bombing in a busy New York City commuter hub will remain in federal custody while he awaits trial on charges that include supporting a foreign terrorist organization, a judge ruled on Wednesday.

healthNews reuters.com

Head and neck cancer survivors have long-lasting cognitive problems

(Reuters Health) - Patients who survive head and neck cancer may be more likely to experience declines in cognitive function than people who don’t have these tumors, a recent study suggests.

healthNews reuters.com

Fears of Israeli job cuts at Teva sparks call for general strike

TEL AVIV (Reuters) - Reports that Teva Pharmaceutical Industries is planning a restructuring involving mass layoffs in Israel sparked calls on Wednesday for a half-day general strike to be held in protest.

healthNews reuters.com

Shift work linked to burnout in sleep-deprived nurses

(Reuters Health) - Shift-work nurses who have sleep problems are more likely to experience career burnout that has the potential to compromise their job performance, a small Italian study suggests.

healthNews reuters.com

Music therapy may help ease depression

(Reuters Health) - Traditional depression treatments like psychotherapy or medication might work better for some patients when doctors add a dose of music therapy, a research review suggests.

healthNews reuters.com

Medtronic settles states' probe into Infuse marketing for $12 million

BOSTON (Reuters) - Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse bone graft product used in spinal surgery, the Massachusetts attorney general said on Wednesday.

healthNews reuters.com

Irish parliament committee backs referendum on abortion up to 12 weeks

DUBLIN (Reuters) - An Irish parliamentary committee on Wednesday recommended that an abortion referendum due next year should offer the choice of allowing terminations with no restrictions up to 12 weeks into a pregnancy, a more liberal position than some had anticipated.

healthNews reuters.com

Revance will wait to seek backing for Botox-rival

(Reuters) - Revance Therapeutics Inc will wait to seek partnerships with bigger drugmakers until it is closer to regulatory approval for its Botox rival treatment, Chief Executive Dan Browne told Reuters in an interview.

businessNews reuters.com

Industrial stocks drive Wall Street higher; Fed decision eyed

(Reuters) - A surge in shares of Caterpillar and Boeing lifted the Dow industrials to record level in early afternoon trading on Wednesday, ahead of a widely-expected interest rate hike by the Federal Reserve.

companyNews reuters.com

US STOCKS-Industrial stocks drive Wall St higher; Fed decision eyed

* U.S. consumer prices rise 0.4 pct in Nov, in line with estimates

healthNews reuters.com

Obamacare sign-ups rise but overall enrollment set to fall

NEW YORK (Reuters) - The number of consumers who signed up for 2018 Obamacare health insurance surpassed the 1 million mark in the second-to-last week of enrollment, the government said on Wednesday, but it did not appear to be enough to grow the program.

healthNews reuters.com

Diabetes and obesity both tied to higher risk of cancer

(Reuters Health) - Many cancer cases worldwide may happen at least in part because people are overweight or have diabetes, a new report suggests.

healthNews reuters.com

Obamacare sign-ups rise to 1 million as pace picks up before deadline

NEW YORK (Reuters) - The number of consumers who signed up for 2018 Obamacare health insurance next year surpassed the 1 million mark in the second-to-last week of enrollment on the federally-run HealthCare.gov website, picking up the pace ahead of the Dec. 15 deadline.

cnn.com

Alabama results and the race for Virginia governor this year reflect trends that could bode well for Democrats

Doug Jones became the first Democrat to win a statewide office in Alabama since 2008, defeating Republican Roy Moore, 49.9% to 48.4%, in a special election Tuesday to fill the Senate seat held by Jeff Sessions before he became Donald Trump's Attorney General. Democrats haven't won a Senate race in Alabama since 1992, back when GOP. Sen. Richard Shelby was still a Democrat (he switched parties in 1994).

healthNews reuters.com

Obamacare sign-ups gain steam as 2018 deadline nears

NEW YORK (Reuters) - More than 1.07 million consumers selected 2018 Obamacare individual insurance plans on the HealthCare.gov website during the week ended Dec. 9, the U.S. government reported on Wednesday, indicating a pick up in the pace of enrollment as the Dec. 15 deadline nears.

healthNews reuters.com

Doner kebabs survive EU lawmaker vote on additives

STRASBOURG (Reuters) - Doner kebab vendors across Europe won a victory in the European Parliament on Wednesday when European Union lawmakers failed to outlaw additives regularly used to preserve taste and moisture.

healthNews reuters.com

Israel's Teva to cut jobs in restructuring on Thursday: report

TEL AVIV (Reuters) - Israel-based Teva Pharmaceutical Industries will unveil a restructuring plan on Thursday that will include laying off more than half its Israeli workforce, the Calcalist financial news website said.

companyNews reuters.com

UPDATE 2-Lilly's 2018 forecast beats on strength of new drugs

Dec 13 (Reuters) - Eli Lilly and Co on Wednesday forecast 2018 profit and revenue ahead of Wall Street estimates on strong demand for recently launched drugs such as Trulicity and Taltz.

healthNews reuters.com

Half of world's people can't get basic health services: WHO

LONDON (Reuters) - At least half the world's population is unable to access essential health services and many others are forced into extreme poverty by having to pay for healthcare they cannot afford, the World Health Organization said on Wednesday.

healthNews reuters.com

Aurora Cannabis wins rights for licensing talks with CannaRoyalty

(Reuters) - Canadian medical marijuana maker Aurora Cannabis Inc has won the rights to negotiate a licensing deal with CannaRoyalty Corp that will allow it to sell a range of cannabis-infused consumer products.

healthNews reuters.com

Philippines' Duterte says dengue campaign carried out in 'good faith'

MANILA (Reuters) - President Rodrigo Duterte believes the previous Philippine government acted in good faith in launching an immunization drive that used a new dengue vaccine on hundreds of thousands of children, he said on Wednesday.

businessNews reuters.com

VW bank expects profit rise in 2017 despite diesel scandal

FRANKFURT (Reuters) - The financial arm of German carmaker Volkswagen said on Wednesday that it expects a rise in operating profit in 2017, despite a diesel scandal that has rocked the industry.

cnn.com

Tour de France champion failed drug test

Chris Froome, who has been the world's most dominant cyclist in recent years, failed a drugs test in one of cycling's most prestigious races earlier this year.

healthNews reuters.com

France's Sanofi pins hopes on new drugs after setbacks

PARIS (Reuters) - French pharmaceuticals group Sanofi said on Wednesday it had suffered from low uptake for a new cholesterol drug and from concerns about a dengue vaccine, but expressed confidence its pipeline of new products would support long-term growth.

companyNews reuters.com

UPDATE 2-France's Sanofi pins hopes on new drugs after setbacks

* CEO says company on track to sell European generics unit (Adds details, shares)

sportsNews reuters.com

Cycling: Froome tested positive for asthma drug during Vuelta

LONDON (Reuters) - Four-time Tour de France winner Chris Froome failed a urine test at the Vuelta a Espana in September but the Briton said on Wednesday he had done nothing wrong.

healthNews reuters.com

Sanofi sees nine regulatory submissions over next 18 months

PARIS (Reuters) - Sanofi said on Wednesday it expected to file nine regulatory submissions for new drugs over the next 18 months and that its pipeline of new products would support long-term growth.

healthNews reuters.com

Teva Pharm to unveil restructuring plan on Thursday: report

TEL AVIV (Reuters) - Israel-based Teva Pharmaceutical Industries will unveil a restructuring plan on Thursday that will include layoffs, the Calcalist financial news website said on Wednesday.

companyNews reuters.com

BRIEF-Regeneron And Sanofi Announce Positive Topline Pivotal Results For Pd-1 Antibody Cemiplimab In Advanced Cutaneous Squamous Cell Carcinoma

* REGENERON AND SANOFI ANNOUNCE POSITIVE TOPLINE PIVOTAL RESULTS FOR PD-1 ANTIBODY CEMIPLIMAB IN ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA

healthNews reuters.com

Did Sanofi, WHO ignore warning signals on dengue vaccine?

CHICAGO/LONDON (Reuters) - When French drugmaker Sanofi published the results of clinical trials of children given its dengue vaccine two years ago, the overall findings were that it protected against the world's biggest and fastest growing mosquito-borne disease.

healthNews reuters.com

U.S. judge questions Trump administration on birth control rules

OAKLAND, Calif. (Reuters) - A U.S. judge questioned on Tuesday whether the federal government properly formulated new rules that undermine an Obamacare requirement for employers to provide insurance that covers women's birth control.

healthNews reuters.com

Republicans propose to delay, pause Obamacare taxes

WASHINGTON (Reuters) - U.S. House Republicans proposed on Tuesday to delay or suspend several taxes under former President Barack Obama's healthcare law, including a tax on medical devices and the so-called "Cadillac" tax on generous health insurance plans.

healthNews reuters.com

Many young U.S. men at high risk for HIV do not take anti-HIV pill

(Reuters Health) - Less than 4 percent of young adult men-who-have-sex-with-men in the U.S. – a population at significant risk of contracting the human immunodeficiency virus (HIV) – reported ever using the pill that protects them from the virus, in a recently published study.

healthNews reuters.com

Older women should not take hormones to prevent chronic diseases

(Reuters Health) - Postmenopausal women should not use hormone therapy to prevent chronic medical conditions, because the risk of significant side effects outweighs the unclear evidence of a benefit, according to a government-backed panel of experts.

healthNews reuters.com

Hearing loss may be a risk factor for dementia

(Reuters Health) - Older adults who develop hearing loss may more likely to experience dementia and cognitive decline than their counterparts without hearing problems, a research review suggests.

companyNews reuters.com

BRIEF-Philip Morris To Make Results From Programs Around IQOS Available By Early 2018

* PHILIP MORRIS INTERNATIONAL SAYS TO MAKE DATA, RESULTS FROM NON-CLINICAL, CLINICAL PROGRAM AROUND IQOS AVAILABLE TO PUBLIC BY EARLY 2018 Source text for Eikon: Further company coverage:

healthNews reuters.com

Motorcycle passengers have higher head injury risks

Reuters Health - Motorcycle passengers are less likely than drivers to wear helmets, and they are more likely to suffer traumatic brain injuries in crashes, a U.S. study suggests.

worldNews reuters.com

France expects slow but massive impact from labor reforms: minister

PARIS (Reuters) - President Emmanuel Macron's labor reforms will be slow to bear fruit but eventually have a massive impact on France's stubbornly high unemployment, his labor minister said Tuesday after data showed a slowdown in new job creation.

healthNews reuters.com

'Heat-not-burn' tobacco may be safer but still a risk: UK panel

LONDON (Reuters) - A new wave of "heat-not-burn" tobacco products are probably safer than traditional cigarettes but the devices still produce a number of potentially harmful compounds, some of which are carcinogenic, a British panel of experts said on Tuesday.

healthNews reuters.com

EU health and food safety experts warn of stubborn salmonella

LONDON (Reuters) - The number of salmonella food poisoning cases in the European Union has risen by 3 percent since 2014 in a "worrying" reversal of a decade-long declining trend, EU health and food safety officials said on Tuesday.

companyNews reuters.com

BRIEF-Jianpu Technology Reports Q3 Unaudited Financial Results

* QTRLY LOSS PER SHARE $0.01 Source text for Eikon: Further company coverage:

businessNews reuters.com

Sanofi investors hungry for drug progress and deal news

PARIS (Reuters) - Sanofi still needs to convince markets it can deliver on an exciting and sustainable growth path as it contends with fresh difficulties in its vaccines arm and looks set for another gloomy year in diabetes, investors told Reuters.

companyNews reuters.com

BRIEF-Tapimmune Announces Enrollment Of First Patient In Phase 2 Clinical Trial For Treating Triple-Negative Breast Cancer

* TAPIMMUNE ANNOUNCES ENROLLMENT OF FIRST PATIENT IN PHASE 2 CLINICAL TRIAL FOR TREATING TRIPLE-NEGATIVE BREAST CANCER FUNDED BY U.S. DEPARTMENT OF DEFENSE

healthNews reuters.com

Cholera resurges in Zambian capital Lusaka, WHO says

GENEVA (Reuters) - Cholera has killed 15 people and made 547 sick in Zambia's capital Lusaka and the rising caseload is expected to grow further as the rainy season starts, according to the World Health Organization.

Brazil nytimes.com

Brazil Fights H.I.V. Spike in Youths With Free Preventive Drug

The country is the first in Latin America to make a blue pill called PrEP an integral part of its health care policy.

companyNews reuters.com

U.S. FDA accepts application for Indivior's new schizophrenia drug

Dec 12 (Reuters) - U.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday, boosting hopes of marketing the drug in the country.

companyNews reuters.com

BRIEF-Autoliv decides on spin-off of Electronics business, expects Q3 listing

* AUTOLIV CONCLUDES STRATEGIC REVIEW AND PREPARES FOR SPIN-OFF OF ITS ELECTRONICS SEGMENT

Wildfires nytimes.com

In California, Mixed Results for Regulations Meant to Help Stop Fires

While the rules can certainly help in slow-moving fires, they have proved no match to the high-wind fires that made this season so destructive.

healthNews reuters.com

NZ's Fisher & Paykel sues Resmed in Australia over patent dispute

(Reuters) - New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.

healthNews reuters.com

Air pollution fine particles linked to poor sperm quality

(Reuters Health) - Exposure to fine particles in air pollution may be another factor that affects men’s sperm quality and their fertility, suggest researchers in Taiwan.

domesticNews reuters.com

U.S. judge warns of mistrial in Nevada rancher Bundy's trial

LAS VEGAS (Reuters) - A U.S. federal judge in the criminal conspiracy trial of Nevada rancher Cliven Bundy and three other men on Monday warned that prosecutors' failure to produce documents that could support defense arguments could lead to a mistrial.

healthNews reuters.com

Retirement linked to longer, better sleep

(Reuters Health) – As work worries abate, sleep difficulties may also diminish when workers make the transition to retirement, according to a recent study from Finland.

cnn.com

How to watch the Alabama special election results

The hotly contested race between Republican Roy Moore and Democrat Doug Jones will come to a close Tuesday when Alabama voters go to the polls for the special Senate election.

companyNews reuters.com

BRIEF-Agios Pharmaceuticals Presents New Safety Data From Study on Leukemia Drug

* PRESENTS NEW SAFETY DATA FROM PHASE 1 EXPANSION STUDY EVALUATING ORAL IVOSIDENIB IN PATIENTS WITH R/R AML AND IDH1 MUTATION

healthNews reuters.com

Amgen's Kyprolis improves overall survival in blood cancer patients

(Reuters) - Amgen Inc said on Monday new data from a late-stage trial testing Kyprolis in combination with two other drugs showed improved overall survival rate in patients with blood cancer.

healthNews reuters.com

Promising responses seen with Agios leukemia drug in study

(Reuters) - Nearly a third of patients with an advanced form of a fast-progressing leukemia who carry a specific genetic mutation experienced a complete or near complete response to an experimental Agios Pharmaceuticals drug, according to data from an early stage trial released on Monday.

healthNews reuters.com

Breast reconstruction after cancer less common at cash-strapped hospitals

(Reuters Health) - Women with breast cancer who have one or both breasts removed are less likely to get immediate reconstruction surgery at hospitals that are struggling financially, a U.S. study suggests.

healthNews reuters.com

Commuters often exposed to damaging noise levels

(Reuters Health) - Loud noise exceeding levels that can damage hearing is regularly encountered by commuters using buses, subways and even biking, a Canadian study suggests.

healthNews reuters.com

Kids continue to die in window-blind accidents, despite safety warnings

(Reuters Health) - Even though window coverings have been recognized for decades as a safety hazard to children, injuries from blinds and shades still send many kids to the emergency room each year, a U.S. study suggests.

healthNews reuters.com

FDA OKs Sanofi's follow-on biologic of Lilly's diabetes drug Humalog

(Reuters) - The U.S. Food and Drug Administration said on Monday it approved Sanofi SA's Admelog as the first follow-on biologic version of Eli Lilly and Co's fast-acting insulin, Humalog.

healthNews reuters.com

Austria to drop impending smoking ban, bucking Western trend

VIENNA (Reuters) - While much of the West has barred smoking in restaurants and bars, Austria's impending ban is set to be stubbed out.

businessNews reuters.com

Ryanair pilots in Dublin vote in favor of industrial action

DUBLIN (Reuters) - Pilots employed directly by Ryanair in Dublin, its second largest base, have voted overwhelmingly in favor of taking industrial action in a growing dispute over the airline's collective bargaining system, the IMPACT trade union said on Monday.

cnn.com

Drug trial shows promising results to fight Huntington's disease

For the first time, an experimental drug has reduced levels of the toxic protein that causes Huntington's disease in humans.

healthNews reuters.com

Opioid painkiller prescriptions may run in families

Reuters Health - When one person in a household gets prescribed opioids, the other people who live with them are more likely to get their own prescriptions for these narcotic painkillers, a U.S. study suggests.

healthNews reuters.com

'Ground-breaking' new drug gives hope in Huntington's disease

LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntington's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

companyNews reuters.com

UPDATE 1-'Ground-breaking' new drug gives hope in Huntington's disease

LONDON, Dec 11 (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntington's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

companyNews reuters.com

BRIEF-Healthcare Realty Trust Expects To Complete Sale Of $300 Mln Of Senior Notes

* HEALTHCARE REALTY TRUST- ON DEC 11, 2017, CO EXPECTS TO COMPLETE SALE OF $300 MILLION AGGREGATE PRINCIPAL AMOUNT OF CO'S 3.625% SENIOR NOTES DUE 2028 Source text: (http://bit.ly/2jvF1sM) Further company coverage:

healthNews reuters.com

'Ground-breaking' new drug gives hope on Huntingdon's disease

LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntingdon's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

companyNews reuters.com

BRIEF-Suning Commerce sells 5.5 mln shares in Alibaba, expects net income of 3.25 bln yuan

* SAYS IT EXPECTS NET INCOME OF 3.25 BILLION YUAN ($491.16 million) AFTER SELLING 5.5 MILLION SHARES IN ALIBABA GROUP HOLDING Source text in Chinese: http://bit.ly/2B32uI0 Further company coverage: ($1 = 6.6170 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

healthNews reuters.com

Indonesia races to contain diphtheria outbreak ahead of 2018 Asian Games

JAKARTA (Reuters) - Health authorities in Jakarta kicked off a special immunization program on Monday to rein in an "extraordinary" outbreak of diphtheria that has sparked concerns about the Indonesian capital’s readiness to host the Asian Games next June. Diphtheria cases have spiked 42 percent since last year, health officials say, with at least 32 deaths and more than 590 cases recorded across the archipelago, the bulk of them in densely populated Jakarta and neighboring provinces.

healthNews reuters.com

GSK's new pharma head on lookout for cancer deals to boost pipeline

LONDON (Reuters) - GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.

healthNews reuters.com

Roche: Tecentriq cocktail slows kidney cancer progression

ZURICH (Reuters) - Combining Roche's Tecentriq immunotherapy with its older drug Avastin reduced the risk of disease worsening or death (PFS) for the initial treatment of advanced kidney cancer in some patients, the Swiss drugmaker said on Monday

healthNews reuters.com

Merck raises stakes in lung cancer as rivals close in

LOS ANGELES (Reuters) - Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer.

sportsNews reuters.com

Ice hockey brothers first bans after NZ drug probe

WELLINGTON (Reuters) - Two brothers who played ice hockey for New Zealand have become the first athletes to be banned after an investigation into the sale of performance-enhancing drugs to amateur sportspeople in the country.

Terrorism nytimes.com

How ISIS Produced Its Cruel Arsenal on an Industrial Scale

When the Islamic State seized territory in Iraq and Syria, it had the time and space to industrialize advanced weapons manufacturing. The results included explosive space heaters and chemical rockets.

healthNews reuters.com

Hospital operators in merger talks to form U.S. industry leader: WSJ

NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in talks about a merger between the two Catholic non-profits that would create the largest U.S. hospital chain, the Wall Street Journal reported on Sunday, citing people familiar with the discussions.

healthNews reuters.com

Hospital operators in merger talks to create U.S. industry leader: WSJ

NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in discussions about a merger that would create the largest hospital chain in the United States, the Wall Street Journal reported on Sunday, citing people familiar with the situation.

healthNews reuters.com

Exclusive: Philippines defied experts' advice in pursuing dengue immunization program

MANILA (Reuters) - As she announced in January 2016 that the Philippines would immunize one million children with a new dengue vaccine, the nation's then health secretary Janette Garin boasted it was a world-first and a tribute to her country's "expertise" in research.

healthNews reuters.com

France orders international recall of Lactalis baby formula

PARIS (Reuters) - France has ordered banned the sale and ordered a recall of several baby formula milk and baby food products made by French dairy giant Lactalis after the discovery of salmonella bacteria, consumer protection agency DGCCRF said in a statement.

healthNews reuters.com

Gilead's new drug keeps 56 percent of lymphoma trial patients alive

(Reuters) - More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results presented on Sunday.

companyNews reuters.com

Gilead's new drug keeps 56 pct of lymphoma trial patients alive

Dec 10 (Reuters) - More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results presented on Sunday.

healthNews reuters.com

Roche lymphoma drug drives high remission rate, longer survival: study

(Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.

companyNews reuters.com

Roche lymphoma drug drives high remission rate, longer survival-study

Dec 10 (Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.

politicsNews reuters.com

Democrats eye gains in Pennsylvania trial on 'goofy' gerrymandering

LOWER MERION, Pa. (Reuters) - In Pennsylvania state Senator Daylin Leach's bid to win a seat vital to the Democratic Party's chances in 2018 elections of taking control of the U.S. Congress, his opponents may not be his biggest obstacle.

Drugs (Pharmaceuticals) nytimes.com

Prescription Drugs May Cost More With Insurance Than Without It

Some consumers are finding they can get a better deal on prescription drugs by leaving their insurance cards at home.

companyNews reuters.com

Drug industry group sues to stop California drug price law

Dec 8 (Reuters) - The trade group representing U.S. drugmakers on Friday said it has a filed a lawsuit to stop California from implementing a law aimed at reining in prescription drug prices.

healthNews reuters.com

U.S. House committee 'may reconsider' WHO cancer agency funds

LONDON (Reuters) - U.S. congressional committee members warned on Friday that Washington's funding of the World Health Organization's cancer research agency could be halted unless it is more open about its operations.

healthNews reuters.com

Lilly's stomach cancer drug meets main goal, but fails to improve survival rate

(Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a gastric cancer treatment met the main goal of preventing the disease from advancing, but failed its secondary target of improving overall survival rates.

companyNews reuters.com

UPDATE 1-Lilly's stomach cancer drug meets main goal, but fails to improve survival rate

Dec 8 (Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a gastric cancer treatment met the main goal of preventing the disease from advancing, but failed its secondary target of improving overall survival rates.

healthNews reuters.com

Lilly's Cyramza meets main goal in gastric cancer study

(Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a treatment for a type of gastric cancer met its main goal of preventing the disease from advancing.

healthNews reuters.com

Depression in late teens linked to high school drop out

(Reuters Health) - Older teens struggling with depression are more than twice as likely to drop out of high school as peers without that mental illness or those who recovered from a bout of depression earlier in life, Canadian researchers say.

politicsNews reuters.com

Mueller turns over evidence for ex-Trump campaign manager Manafort's trial

WASHINGTON (Reuters) - U.S. Special Counsel Robert Mueller has turned over more than 400,000 emails, financial records and other documents to defense attorneys for President Donald Trump's former campaign manager Paul Manafort to demonstrate what evidence the government has against him, according to a court filing on Friday.

companyNews reuters.com

CANADA STOCKS-TSX posts 2-week high as industrials lead broad-based rally

TORONTO, Dec 8 (Reuters) - Canada's main stock index rose to a two-week high on Friday, led by financial and industrial shares after solid U.S. jobs data boosted investor sentiment, while energy stocks climbed on higher oil prices.

companyNews reuters.com

BRIEF-Platform Specialty Products Announces Final Results Of Cash Tender Offer

* PLATFORM SPECIALTY PRODUCTS CORPORATION ANNOUNCES FINAL RESULTS OF CASH TENDER OFFER AND CONSENT SOLICITATION FOR, AND COMPLETION OF THE REDEMPTION OF, ANY AND ALL OF ITS OUTSTANDING 10.375% SENIOR NOTES DUE 2021 Source text for Eikon: Further company coverage:

healthNews reuters.com

Kids who get moving may also get better grades

(Reuters Health) - Students who get extra physical activity may pay more attention in school and do better in subjects like reading and math, a research review suggests.

healthNews reuters.com

Acupressure app may help ease menstrual cramp pain

(Reuters Health) - Women with intense menstrual cramp pain may get more relief from smartphone app-guided acupressure than with typical medical treatments like painkillers, a recent study suggests.

healthNews reuters.com

Credibility, recipes, references help food blogs improve eating habits

(Reuters Health) - Consumers like healthy eating blogs written by nutritionists who seem credible and who interact with their readers, a small study in Canada suggests.

healthNews reuters.com

Uganda says it has contained an outbreak of Marburg hemorrhagic fever

KAMPALA (Reuters) - Uganda said on Friday it had successfully contained an outbreak of the Marburg virus, a highly infectious haemorrhagic fever announced by officials on Oct. 19, which killed three people.

businessNews reuters.com

CVS expects Justice Department to handle review of Aetna deal

WASHINGTON (Reuters) - CVS Health Corp expects the U.S. Justice Department to do the antitrust review of its planned acquisition of health insurer Aetna Inc, a spokesman for the drugstore chain operator said.

companyNews reuters.com

UPDATE 1-CVS expects U.S. Justice Department to handle review of Aetna deal

WASHINGTON, Dec 7 (Reuters) - CVS Health Corp expects the U.S. Justice Department to do the antitrust review of its planned acquisition of health insurer Aetna Inc, a spokesman for the drugstore chain operator said.

companyNews reuters.com

CVS expects U.S. Justice Department to handle review of Aetna deal

WASHINGTON, Dec 7 (Reuters) - U.S. drugstore chain operator CVS Health Corp expects the Justice Department to do the antitrust review of its planned acquisition of health insurer Aetna Inc, a spokesman said.

healthNews reuters.com

Pfizer breast cancer drug superior to chemotherapy in late stage study

(Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.

companyNews reuters.com

Pfizer breast cancer drug superior to chemotherapy in Phase III study

Dec 8 (Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.

healthNews reuters.com

Top Russian pork producer Miratorg reports ASF outbreak

MOSCOW (Reuters) - Russia's largest pork producer Miratorg on Friday reported an outbreak of African Swine Fever (ASF) at one of its sites in the Belgorod region in central Russia.

sportsNews reuters.com

Peru's Guerrero to miss World Cup after drugs ban

(Reuters) - Peru's hopes at next year's World Cup finals were dealt a huge blow when captain and all-time record goalscorer Paolo Guerrero was banned for one year on Friday after failing an anti-doping test for cocaine.

businessNews reuters.com

Roche, Novartis' Italian heads risk trial for alleged market rigging: sources

ROME (Reuters) - The local heads of Swiss drugmakers Roche and Novartis risk facing trial in Italy for alleged market manipulation, judicial sources said on Friday.

healthNews reuters.com

Venezuela's chronic shortages give rise to 'medical flea markets'

SAN CRISTOBAL/MARACAIBO, Venezuela (Reuters) - Venezuela's critical medicine shortage has spurred "medical flea markets," where peddlers offer everything from antibiotics to contraceptives laid out among the traditional fruits and vegetables.

healthNews reuters.com

Russia's meat firm Miratorg reports ASF outbreak at 1 site in Russia

MOSCOW (Reuters) - Russian privately-owned meat producer Miratorg said on Friday there was an outbreak of African Swine Fever (ASF) at one of its sites in Russia's Belgorod region.

sportsNews reuters.com

FIFA bans Peru skipper Guerrero for one year for drug offence

ZURICH (Reuters) - FIFA's disciplinary committee has banned Peruvian soccer captain Paulo Guerrero for one year after he failed a doping test, the watchdog said on Friday.

worldNews reuters.com

Trial over 'Love Parade' deaths begins in Germany

BERLIN (Reuters) - Ten people went on trial in Germany on Friday for alleged failures in planning the "Love Parade" music festival in 2010 when 21 people were killed and more than 650 injured in a stampede.

healthNews reuters.com

Philippines to seek refund of $59 million from Sanofi amid vaccine risk

MANILA (Reuters) - The Philippines will seek the return of 3 billion pesos ($59 million) it paid French drugmaker Sanofi for a dengue vaccine used to immunize hundreds of thousands of children that Sanofi has said could worsen the disease in some cases.

worldNews reuters.com

Vatican should bring money-laundering cases to trial, watchdog agency says

VATICAN CITY (Reuters) - The Vatican needs to bring cases of suspected money laundering to trial, a European finance watchdog urged on Friday, saying the good progress made by its financial regulators needed to be matched by judicial muscle.

healthNews reuters.com

Roche study finds cancer 'Velcro' that halts T-cell attack

ZURICH (Reuters) - Scientists at Swiss drugmaker Roche said on Friday they may have discovered why some tumors resist new immunotherapy drugs as well as a possible means of turning the tables to incite a T-cell attack.

healthNews reuters.com

U.S. Department of Justice investigating fetal tissue transfers

(Reuters) - The U.S. Department of Justice asked on Thursday for documents related to a Senate committee's report on the transfer of fetal tissue by abortion provider Planned Parenthood, according to a letter seen by Reuters.

healthNews reuters.com

U.S. Department of Justice seeks documents on fetal tissue transfers

(Reuters) - The U.S. Department of Justice sent a letter on Thursday, seen by Reuters, seeking documents related to a Senate committee's report on the transfer of fetal tissue by abortion provider Planned Parenthood.

Drug Abuse and Traffic nytimes.com

A Comeback for the Gateway Drug Theory?

As marijuana legalization and the opioid epidemic sweep across the country, new research is breathing fresh life into the perennial debate.

technologyNews reuters.com

Spark NZ expects to roll out 5G in next few years

(Reuters) - New Zealand telecommunications company Spark New Zealand said on Friday its plans for a fifth-generation network (5G) are progressing well and it expects to roll it out within the "next few years."

healthNews reuters.com

Antibiotics sales for use in U.S. farm animals dropped in 2016: FDA

CHICAGO (Reuters) - The sale and distribution of antibiotics approved for use in food-producing animals in the United States decreased by 10 percent from 2015 to 2016, a U.S. Food and Drug Administration (FDA) report said on Thursday.

cnn.com

Trial date set for AT&T, Time Warner case

companyNews reuters.com

BRIEF-Medicinova Announces Positive Top-Line Results From Clinical Trial Of MN-166 (ibudilast) In ALS

* MEDICINOVA ANNOUNCES POSITIVE TOP-LINE RESULTS FROM THE CLINICAL TRIAL OF MN-166 (IBUDILAST) IN ALS

companyNews reuters.com

UPDATE 3-AT&T/Time Warner antitrust trial set for March

WASHINGTON, Dec 7 (Reuters) - The trial to determine if the U.S. Department of Justice can stop AT&T Inc's $85 billion purchase of media company Time Warner Inc will begin on March 19 with no decision expected before the companies' April 22 deadline to complete the deal, a federal judge said on Thursday.

healthNews reuters.com

Childhood cancer survivors have more blood pressure problems

(Reuters Health) - More than one in 12 adult survivors of childhood cancers may have undiagnosed high blood pressure, a U.S. study suggests.

businessNews reuters.com

AT&T/Time Warner antitrust trial set for March

WASHINGTON (Reuters) - The trial to determine if the U.S. Department of Justice can stop AT&T Inc's $85 billion purchase of media company Time Warner Inc will begin on March 19, a federal judge in Washington said during a hearing on Thursday.

companyNews reuters.com

UPDATE 2-AT&T/Time Warner antitrust trial set for March

WASHINGTON, Dec 7 (Reuters) - The trial to determine if the U.S. Department of Justice can stop AT&T Inc's $85 billion purchase of media company Time Warner Inc will begin on March 19, a federal judge in Washington said during a hearing on Thursday.

sportsNews reuters.com

U.S expects to participate in Winter Olympics - White House

WASHINGTON (Reuters) - White House Press Secretary Sarah Sanders on Thursday said the United States looks forward to participating in the Olympics Winter Games in South Korea in February, after questions arose about security in the neighbor to North Korea, which has recently ramped up weapons testing.

healthNews reuters.com

Faulty positioning in rugby tackles boosts injury risk

(Reuters Health) - Head, neck and shoulder injuries during rugby tackles are more common when the tackler’s head is incorrectly positioned in relation to the ball carrier, a small study has found.

healthNews reuters.com

Gum infections tied to increased risk of stomach cancer precursor

(Reuters Health) - Gum infections may increase people’s risk for sores in the digestive tract that can lead to stomach cancer, a small study suggests.

healthNews reuters.com

Open windows and doors can improve sleep quality

(Reuters Health) - Leaving a bedroom door or window open may help people sleep better, a study from the Netherlands suggests.

healthNews reuters.com

Sage shares surge as depression drug succeeds in mid-stage trial

(Reuters) - Drug developer Sage Therapeutics Inc's shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the symptoms of depression succeeded in a mid-stage trial.

companyNews reuters.com

UPDATE 3-Sage shares surge as depression drug succeeds in mid-stage trial

* Shares surge as much as 85 pct (Adds details on drug's mechanism, analyst comment, updates shares)

companyNews reuters.com

UPDATE 5-Roche drug cocktail doubles chance of holding lung cancer at bay

* Analysts see drug sales topping $4.6 bln by 2023 - poll (Adds analyst comment)

companyNews reuters.com

BRIEF-Cantel Medical Reports Record Financial Results For Q1 Fiscal Year 2018

* Q1 EARNINGS PER SHARE VIEW $0.54 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

healthNews reuters.com

South African egg prices seen rising 20 percent after avian flu outbreak

JOHANNESBURG (Reuters) - Egg prices in South Africa are expected to increase by as much as 20 percent after an outbreak of the highly pathogenic avian flu in June forced farmers to cull egg laying birds, industry experts said on Thursday.

healthNews reuters.com

More than 2,000 drugs now in cancer immunotherapy race

LONDON (Reuters) - The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development.

companyNews reuters.com

BRIEF-Aeromexico Reports November 2017 Traffic Results

* GRUPO AEROMEXICO SAB DE CV - ‍NOVEMBER DEMAND, MEASURED IN REVENUE PASSENGER KILOMETERS (RPKS), INCREASED BY 19.7%, YEAR-ON-YEAR​

healthNews reuters.com

Sage shares surge as depression drug succeeds mid-stage trial

(Reuters) - Sage Therapeutics Inc's shares surged more than 63 percent premarket on Thursday, on track to add about $2.5 billion to the company's market value, after its drug succeeded in reducing the symptoms of depression in a mid-stage trial.

companyNews reuters.com

BRIEF-Kalytera Therapeutics Says ‍Results Of Phase 2 Clinical Study In Prevention Of Graft Versus Host Disease​ Are Expected By Q3 2018

* KALYTERA ANNOUNCES INITIATION OF PHASE 2 CLINICAL STUDY IN PREVENTION OF GRAFT VERSUS HOST DISEASE AND AGREEMENT WITH THE SALZMAN GROUP OF ISRAEL TO MANAGE AND PARTIALLY FUND THE STUDY TO BE LED BY A WORLD CLASS TEAM

companyNews reuters.com

BRIEF-Dicerna Announces First Human Dosed In Phase 1 Clinical Trial Of DCR-PHXC

* DICERNA ANNOUNCES FIRST HUMAN DOSED IN PHASE 1 CLINICAL TRIAL OF DCR-PHXC FOR TREATMENT OF ALL FORMS OF PRIMARY HYPEROXALURIA

healthNews reuters.com

Sage's depression drug succeeds in mid-stage study, shares soar

(Reuters) - Sage Therapeutics Inc said on Thursday its drug to treat patients with moderate to severe depression met the main goal of reducing symptoms in a mid-stage study, sending its shares soaring 52.3 percent in premarket trading.

companyNews reuters.com

UPDATE 1-Sage's depression drug succeeds in mid-stage study, shares soar

Dec 7 (Reuters) - Sage Therapeutics Inc said on Thursday its drug to treat patients with moderate to severe depression met the main goal of reducing symptoms in a mid-stage study, sending its shares soaring 52.3 percent in premarket trading.

businessNews reuters.com

AT&T/Time Warner antitrust hearing to focus on trial date

WASHINGTON (Reuters) - The U.S. Department of Justice and AT&T Inc will meet in court for the first time on Thursday as the antitrust regulator attempts to stop the U.S. No. 2 wireless company's $85 billion purchase of media company Time Warner Inc .

healthNews reuters.com

Indonesia fights 'extraordinary' diphtheria outbreak that has killed 32

JAKARTA (Reuters) - Indonesian health authorities will launch an immunization drive next week to contain a sharp rise in cases of diphtheria, which has killed at least 32 people, including many children, in the world's fourth most populous country this year.

companyNews reuters.com

UPDATE 3-Roche drug cocktail doubles chance of holding lung cancer at bay

* Tecentriq drug cocktail cuts risk of disease progressing by 38 pct

worldNews reuters.com

Pro-Kurdish opposition leader goes on trial in Turkey on terror-related charges

ANKARA (Reuters) - The jailed leader of Turkey's pro-Kurdish opposition went on trial on Thursday, 13 months after his arrest on terrorism-related charges, facing up to 142 years in prison in a case closely watched by rights groups and Western governments.

companyNews reuters.com

UPDATE 2-Roche drug cocktail doubles chance of holding lung cancer at bay

* Tecentriq drug cocktail cuts risk of disease progressing by 38 pct

companyNews reuters.com

UPDATE 1-Roche drug cocktail doubles chance of holding lung cancer at bay

ZURICH, Dec 7 (Reuters) - Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease advancing, an outcome some experts labeled unprecedented.

companyNews reuters.com

BRIEF-Genentech Announces Positive Interim Results From Phase 3 Study Evaluating Hemlibra

* GENENTECH-POSITIVE INTERIM RESULTS FROM PHASE III EVALUATING HEMLIBRA DOSED ONCE EVERY FOUR WEEKS IN ADULTS AND ADOLESCENTS WITH HEMOPHILIA A

companyNews reuters.com

Roche drug cocktail doubles chance of holding lung cancer at bay

ZURICH, Dec 7 (Reuters) - Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease advancing, an outcome some experts labeled unprecedented.

companyNews reuters.com

BRIEF-Schaffner Holding Expects Ebit Margin In Mid-Single Digits For Fiscal Year 2017/18

* SCHAFFNER HOLDING AG SAYS EBIT MARGIN IN MID-SINGLE DIGITS IS CURRENTLY EXPECTED FOR FISCAL YEAR 2017/18

healthNews reuters.com

Knee surgery outcomes linked with education level

(Reuters Health) - Patients who live in low-income communities and lack a college education may have worse pain after knee replacement surgery than their more educated neighbors, a recent study suggests.

healthNews reuters.com

Study confirms higher breast cancer risk with hormone-based contraception

(Reuters Health) - Women who currently use or recently used hormone-based contraception face a 20 percent higher risk of breast cancer, although the overall risk for most women is relatively low, a new study of 1.8 million women in Denmark has concluded.

healthNews reuters.com

U.S. healthcare spending growth slowed in 2016

(Reuters) - Growth in healthcare spending in the United States slowed in 2016 following two years of expansion under the Affordable Care Act, a government health agency reported on Wednesday.

healthNews reuters.com

Home births in rural areas just as safe as in cities

(Reuters Health) - Home births may not be more dangerous for healthy rural mothers than for their urban counterparts, a recent U.S. study suggests.

healthNews reuters.com

Roche to seize leap-frog opportunity in lung cancer

LONDON (Reuters) - After lagging rivals in cancer immunotherapies, Swiss drugmaker Roche hopes to leap-frog into the lead in the biggest market, tackling previously untreated lung cancer.

healthNews reuters.com

Kids aren’t protecting themselves against STDs during oral sex

(Reuters Health) - Adolescents and young adults regularly engage in oral sex but seldom use condoms to prevent the spread of sexually transmitted diseases, new research shows.

healthNews reuters.com

FDA proposes drug development guidance for rare pediatric diseases

(Reuters) - The U.S. Food and Drug Administration issued a draft guidance on Wednesday to simplify the procedure of developing drugs for rare pediatric disorders, such as Gaucher's disease, by eliminating the need for certain trials and minimizing patient enrollment.

companyNews reuters.com

UPDATE 2-American Eagle expects strong holiday earnings but lower margins

* Shares rise 5 pct but pare gains after margins forecast (Adds executive and analyst comments, updates share price)

healthNews reuters.com

Sign-ups pick up in week five of 2018 Obamacare open enrollment - U.S.

WASHINGTON (Reuters) - The number of people signing up for 2018 Obamacare plans picked up significantly during the fifth week of open enrollment, a U.S. government agency reported on Wednesday, but the number of people signed up for such plans appears to be falling short of last year's numbers with just over a week of enrollment left.

healthNews reuters.com

Myanmar's opium crop plummets, but no victory over Asia's narco-boom: U.N.

BANGKOK (Reuters) - A "dramatic" drop in opium cultivation in Myanmar underscored a regional boom in demand for illegal synthetic drugs such as methamphetamine, which many Asian countries are struggling to combat, a senior U.N. official said on Wednesday.

companyNews reuters.com

BRIEF-Prudential Financial announces early participation results

* PRUDENTIAL FINANCIAL, INC. ANNOUNCES EARLY PARTICIPATION RESULTS AND EARLY SETTLEMENT ELECTION OF ITS PRIVATE EXCHANGE OFFERS OF CERTAIN OUTSTANDING NOTES FOR NEW NOTES

companyNews reuters.com

BRIEF-Amazon.com Announces Early Participation Results Of Exchange Offer

* AMAZON.COM, INC. ANNOUNCES EARLY PARTICIPATION RESULTS OF EXCHANGE OFFER AND CONSENT SOLICITATION FOR WHOLE FOODS MARKET, INC. 5.200% NOTES DUE 2025 Source text for Eikon: Further company coverage:

companyNews reuters.com

BRIEF-Pfizer Announces Updated Progression-Free Survival Results

* UPDATED DATA FROM PHASE 3 TRIAL OF IBRANCE® (PALBOCICLIB) PLUS LETROZOLE IN ER+, HER2- METASTATIC BREAST CANCER CONFIRM IMPROVEMENT IN PROGRESSION-FREE SURVIVAL

companyNews reuters.com

BRIEF-Novo Nordisk expects to launch new diabetes drug in Japan during H1 2018

Dec 6 (Reuters) - NOVO NORDISK A/S CHIEF SCIENTIFIC OFFICER MADS KROGSGAARD THOMSEN MADE FOLLOWING COMMENTS DURING AN INVESTOR CALL FOLLOWING U.S. APPROVAL OF DIABETES DRUG OZEMPIC:

healthNews reuters.com

GSK, other drugmakers bet on post-Brexit UK science

LONDON (Reuters) - Britain won a vote of confidence from its economically important life sciences sector on Wednesday as five drug companies committed to invest in the country under the government's industrial strategy plans after Brexit.

companyNews reuters.com

REFILE-Gold trader says he never liked Turkish banker facing trial

(Refiles to add dropped text in final two paragraphs.) By Brendan Pierson NEW YORK, Dec 5 (Reuters) - A Turkish gold trader testifying for U.S. prosecutors in the trial of an executive at Turkey's state-owned Halkbank, who is charged with helping Iran evade U.S. sanctions, said Tuesday that he and the banker never liked each other. Reza Zarrab, who has pleaded guilty and is cooperating with U.S. prosecutors in the case, also said he had complained about Halkbank deputy ge

healthNews reuters.com

Australian watchdog takes GlaxoSmithKline, Novartis units to court

(Reuters) - The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.

healthNews reuters.com

Consistently lower cancer survival rates for black patients in U.S.

(Reuters Health) - Whether it's colon cancer, breast cancer, or ovarian cancer, survival rates in the U.S. are lower for black people than for white people, three new studies show.

healthNews reuters.com

Brazil, U.S. identify molecule to help fight citrus greening disease

SAO PAULO (Reuters) - Researchers have identified the molecule that attracts the insect that transmits citrus greening disease, a development expected to help farmers control a plague that has destroyed trees in growing regions of Brazil and the United States.

domesticNews reuters.com

Gold trader says he never liked Turkish banker facing trial

NEW YORK (Reuters) - A Turkish gold trader testifying for U.S. prosecutors in the trial of an executive at Turkey's state-owned Halkbank, who is charged with helping Iran evade U.S. sanctions, said Tuesday that he and the banker never liked each other.

healthNews reuters.com

Paraguay Congress legalizes planting of medical marijuana

ASUNCION (Reuters) - Paraguay's Congress passed a bill on Tuesday creating a state-sponsored system to import marijuana seeds and grow the plant for medical uses, a decision that followed other countries in Latin America.

healthNews reuters.com

Eating almonds with chocolate may lower cholesterol

(Reuters Health) - Overweight and obese people who eat almonds and chocolate every day may have lower cholesterol than their counterparts who don’t consume these foods, a recent experiment suggests.

healthNews reuters.com

Hospital patients are safe with substitute doctors

(Reuters Health) - Hospital patients’ survival rates don’t suffer when fill-in doctors substitute for the regular staff physicians, a U.S. study suggests.

companyNews reuters.com

UPDATE 2-U.S. FDA approves Novo Nordisk diabetes drug Ozempic

Dec 5 (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated battle with Eli Lilly & Co's Trulicity.

healthNews reuters.com

Women get mixed messages about sexuality after childbirth

(Reuters Health) - Women receive mixed messages about the ways giving birth may affect their sex lives, according to a new report.

healthNews reuters.com

FDA approves Novo Nordisk diabetes drug Ozempic

(Reuters) - The U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated competitive battle with Eli Lilly & Co's Trulicity.

businessNews reuters.com

Sprint expects pace of customer defections to slow in holiday quarter

(Reuters) - U.S. wireless carrier Sprint Corp expects the pace of customer defections to slow in the key holiday quarter, helped by higher promotions, its chief financial officer said on Tuesday.